A Plasma Cell Granuloma in the lungs is a lump-like area of inflammation made up of plasma cells, a type of immune cell. It's sometimes called an inflammatory pseudotumor. These can be found in the lungs and might look like a tumor.
Every report comes from a Lived member, sent anonymously.
Have you had Lung Surgery for Pulmonary Plasma Cell Granuloma?
A pulmonary plasma cell granuloma is a rare, solid mass in the lung made of spindle-shaped connective tissue cells mixed with large numbers of inflammatory cells, especially plasma cells (the white blood cells that make antibodies). Because it can look like a tumor on a scan yet contains so much inflammation, it was long called an inflammatory pseudotumor, meaning "false tumor." That name has changed as doctors learned more. Most lesions once called plasma cell granuloma are now classified as inflammatory myofibroblastic tumor (IMT). This is a true tumor, but one of intermediate behavior: it can grow, press on or invade nearby tissue and come back after surgery, yet it rarely spreads to distant parts of the body. A smaller group of these lesions are purely inflammatory reactions rather than tumors. Working out which kind a person has is a central part of care. These masses account for up to about 1% of lung tumors. They are found most often in children and young adults, but they occur at any age. Many people have a cough, chest pain or shortness of breath, and some cough up blood. About a quarter of people have no symptoms, and the mass is found on a scan done for another reason. Some people also feel generally unwell, with fever, tiredness or weight loss.
In most cases no clear cause is found. Researchers have suggested several possible contributors, including past inflammation or infection, injury, autoimmune conditions and earlier surgery, but none has been shown to cause an individual case. About half of these tumors carry a rearrangement of a gene called ALK (anaplastic lymphoma kinase) in the tumor cells. This rearrangement switches on a growth signal, and it is the main reason the condition is now regarded as a true tumor. Other tumors carry similar rearrangements in related genes such as ROS1 or NTRK. These findings matter mostly because they open the door to targeted medicines. A minority of lung masses with this appearance are reactive rather than tumors. Some follow an infection, and some are part of IgG4-related disease, an immune condition in which plasma cells producing one type of antibody (IgG4) build up and cause scarring in one or more organs.
A plasma cell granuloma usually first appears as a spot or mass on a chest X-ray or CT (computed tomography) scan. On CT it is often a well-defined, rounded mass, frequently in the outer part of a lower lobe, and about a third contain calcium deposits. It may also show high activity on a PET (positron emission tomography) scan, which measures how much sugar tissue is using. That means it can look very much like lung cancer, a carcinoid tumor or a fungal or bacterial infection, and imaging alone cannot settle the question. The diagnosis depends on examining tissue under a microscope. A sample may be taken with a needle through the chest wall or through a bronchoscope, a thin camera passed into the airways. Needle samples are sometimes too small to be conclusive, so the diagnosis is often confirmed only after the whole mass has been removed. The pathologist also tests the tissue for the ALK protein and, if needed, for rearrangements in ALK, ROS1, NTRK and related genes. These results help confirm the diagnosis and show whether targeted medicine could be an option. Staining for IgG4-producing plasma cells helps identify IgG4-related disease. Blood tests may show anemia, a high platelet count or raised markers of inflammation (such as the sedimentation rate and C-reactive protein), which support the picture but do not make the diagnosis.
Surgery to remove the entire mass with a margin of healthy tissue is the main treatment, and it often serves to confirm the diagnosis at the same time. Depending on size and position, this can mean removing a small wedge of lung, a segment, a whole lobe or, for very large or invasive masses, an entire lung. Many operations can be done with video-assisted thoracoscopic surgery (VATS), a keyhole approach that usually means less pain and a shorter recovery than open surgery. How completely the mass is removed is the biggest factor in whether it comes back. In published case collections, recurrence after complete removal is about 2%, compared with as high as 60% when some tumor is left behind. A tumor that does come back is usually removed again if possible. When a tumor cannot be fully removed, returns, or has spread, medicine becomes more important. For ALK-positive tumors, crizotinib (Xalkori), a daily pill that blocks the ALK growth signal, is approved by the U.S. Food and Drug Administration (FDA) for adults and children 1 year and older, and other ALK-blocking medicines can be used if it stops working. Tumors with ROS1 or NTRK rearrangements may respond to medicines aimed at those signals. Chemotherapy and radiation therapy are reserved for situations where surgery and targeted medicine are not enough. Anti-inflammatory treatment has a narrower role. Corticosteroids (steroid medicines such as prednisone) can shrink lesions that are IgG4-related or mainly inflammatory, and steroids or anti-inflammatory painkillers have helped some people with tumors that could not be removed. Reports suggest steroids may not prevent, and might encourage, regrowth of true tumors, so they are not a substitute for surgery when surgery is possible.
When the mass is completely removed, the outlook is usually excellent. In one long-term surgical series, five-year survival was 91%, no one died from the operation and none of the deaths during follow-up were caused by the pseudotumor. Fever, tiredness and other whole-body symptoms, when present, typically settle after the tumor is removed. Recovery depends mainly on the operation. Keyhole surgery to remove a small piece of lung usually allows a quicker return to normal activity than open surgery or removal of a whole lobe or lung. The surgical team will explain what to expect for breathing, pain and activity after the specific procedure planned. Follow-up continues for years. Regrowth is uncommon after complete removal, but it has been reported more than a decade later, so periodic check-ups and scans are generally recommended. People whose tumor could not be fully removed, or who take a targeted medicine, need closer monitoring of how the tumor responds and of medicine side effects. Because the condition is rare, the evidence comes mainly from individual case reports and small series rather than trials, and published rates of recurrence or spread are approximate.
Arrange follow-up promptly if a scan shows an unexplained lung mass, or if you have a cough, chest pain or shortness of breath that lasts for weeks without a clear cause. A lung mass needs a diagnosis rather than watchful waiting, since it can resemble lung cancer. If you have been treated, contact your care team if a cough, chest pain or breathlessness returns, or if you develop unexplained fever or weight loss, since these can be signs of regrowth. Get emergency care right away if you cough up more than a few teaspoons of blood or become severely short of breath.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Pulmonary Plasma Cell Granuloma is like, what's helped you, or ask the community a question.